Clearline Capital’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,662
| Closed | -$164K | – | 163 |
|
|
2024
Q2 | $164K | Hold |
20,662
| – | – | ﹤0.01% | 139 |
|
|
2024
Q1 | $331K | Hold |
20,662
| – | – | 0.02% | 114 |
|
|
2023
Q4 | $283K | Hold |
20,662
| – | – | 0.02% | 94 |
|
|
2023
Q3 | $302K | Sell |
20,662
-29,681
| -59% | -$434K | 0.03% | 118 |
|
|
2023
Q2 | $856K | Hold |
50,343
| – | – | 0.05% | 90 |
|
|
2023
Q1 | $703K | Hold |
50,343
| – | – | 0.11% | 84 |
|
|
2022
Q4 | $332K | Hold |
50,343
| – | – | 0.06% | 107 |
|
|
2022
Q3 | $265K | Hold |
50,343
| – | – | 0.03% | 127 |
|
|
2022
Q2 | $239K | Hold |
50,343
| – | – | 0.03% | 119 |
|
|
2022
Q1 | $427K | Hold |
50,343
| – | – | 0.05% | 110 |
|
|
2021
Q4 | $603K | Hold |
50,343
| – | – | 0.07% | 105 |
|
|
2021
Q3 | $892K | Hold |
50,343
| – | – | 0.08% | 105 |
|
|
2021
Q2 | $1.03M | Buy |
50,343
+10,937
| +28% | +$224K | 0.15% | 90 |
|
|
2021
Q1 | $781K | Sell |
39,406
-51,300
| -57% | -$1.02M | 0.1% | 79 |
|
|
2020
Q4 | $1.69M | Buy |
+90,706
| New | +$1.69M | 0.38% | 58 |
|